17 Capital Partners LLC Boosts Holdings in Intuitive Surgical, Inc. $ISRG

17 Capital Partners LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,041 shares of the medical equipment provider’s stock after buying an additional 150 shares during the period. 17 Capital Partners LLC’s holdings in Intuitive Surgical were worth $1,109,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the company. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the period. PFG Advisors raised its holdings in shares of Intuitive Surgical by 31.4% in the first quarter. PFG Advisors now owns 7,670 shares of the medical equipment provider’s stock valued at $3,799,000 after buying an additional 1,833 shares during the last quarter. Proficio Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 2.9% during the first quarter. Proficio Capital Partners LLC now owns 1,872 shares of the medical equipment provider’s stock worth $927,000 after buying an additional 52 shares during the period. Oak Thistle LLC acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $2,359,000. Finally, SYM FINANCIAL Corp purchased a new position in shares of Intuitive Surgical during the first quarter worth about $1,120,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 116,164 shares of company stock valued at $61,916,172 in the last 90 days. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have commented on ISRG shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. HSBC lifted their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Finally, Truist Financial set a $620.00 target price on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $564.64 on Thursday. The company has a market cap of $202.41 billion, a P/E ratio of 74.69, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business has a fifty day moving average of $487.92 and a two-hundred day moving average of $503.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.84 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.